Titre : | AB-CHMINACA. Report on the risk assessment of N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) in the framework of the Council Decision on new psychoactive substances |
Auteurs : | OEDT = EMCDDA |
Type de document : | Rapport |
Editeur : | Lisbon : OEDT / EMCDDA, 2018 |
Autre Editeur : | Luxembourg : Publications Office of the European Union |
Collection : | Risk assessments, ISSN 1725-4493, num. 24 |
Format : | 67 p. |
Langues: | Anglais |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Mots-clés : |
Organismes OEDTThésaurus mots-clés CANNABINOIDES ; CONTROLE DES STUPEFIANTS ; FACTEUR DE RISQUE ; DROGUES DE SYNTHESE ; PHARMACOLOGIE ; TYPE D'USAGE ; EFFET SECONDAIRE ; TOXICITE ; INTOXICATION ; MORTALITE ; SURVEILLANCE EPIDEMIOLOGIQUEThésaurus géographique EUROPE |
Résumé : | This publication presents the data and findings of the risk assessment on N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. In March 2018, at its 61st regular session, the Commission on Narcotic Drugs (CND) decided to place AB-CHMINACA in Schedule II of the Convention on Psychotropic Substances of 1971 based on a recommendation by the World Health Organization. This recommendation was substantially supported by European data provided by the EMCDDA. |
Note de contenu : |
TABLE OF CONTENTS:
- Foreword. - EMCDDA actions on monitoring and responding to new drugs Europol-EMCDDA Joint Report on AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) - a summary. - Risk Assessment Report on a new psychoactive substance: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA). - Technical report on N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA). - Participants of the risk assessment meeting, 7-8 November 2017. |
Domaine : | Drogues illicites / Illicit drugs |
Lien : | http://www.emcdda.europa.eu/publications/risk-assessments/ab-chminaca_en |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Documents numériques (1)
![]() EMCDDA_AB-CHMINACA_2018.pdf Adobe Acrobat PDF |
